Effect of cyclosporin A on functional recovery in the spinal cord following contusion injury

Journal of Anatomy

Volumn 215, Issue 3, 2009, Pages 267-279

  Mcmahon, Siobhan S ^a   Albermann, Silke ^a   Rooney, Gemma E ^a   Moran, Cathal ^a   Hynes, Jacqueline ^a   Garcia, Yolanda ^a   Dockery, Peter ^a   O'brien, Timothy ^a   Windebank, Anthony J ^b   Barry, Frank P ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b MAYO CLINIC   (United States)

Author keywords

Glial scar; Motor function; Regeneration; Spinal cord injury; Stereology

Indexed keywords

ANTIINFECTIVE AGENT; BUTORPHANOL TARTRATE; CYCLOSPORIN A; ENROFLOXACIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INTERACTION; CONTROLLED STUDY; CONTUSION; DRUG ACTIVITY; DRUG EFFICACY; FEMALE; FUNCTIONAL ASSESSMENT; LIPID PEROXIDATION; LOCOMOTION; MICROENVIRONMENT; MOTOR PERFORMANCE; NERVE LESION; NERVE REGENERATION; NEUROPROTECTION; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; RAT; SPINAL CORD INJURY; TISSUE PREPARATION; URINARY TRACT INFECTION;

ANIMALS; COLLAGEN; CYCLOSPORINE; DRUG EVALUATION, PRECLINICAL; FEMALE; HINDLIMB; MICROSCOPY, ELECTRON, SCANNING; NERVE REGENERATION; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; SPINAL CORD; SPINAL CORD INJURIES;

ANIMALIA; RATTUS;

EID: 69249203791     PISSN: 00218782     EISSN: 14697580     Source Type: Journal    
DOI: 10.1111/j.1469-7580.2009.01107.x     Document Type: Article

References (48)

1. Anderberg L, Aldskogius H, Holtz A (2007) Spinal cord injury -scientific challenges for the unknown future. Ups J Med Sci 112, 259-288.
2. Begley DJ., Squires LK, Zloković BV, et al. (1990) Permeability of the blood-brain barrier to the immunosuppressive cyclic peptide cyclosporin A. J Neurochem 55, 1222-1230.
3. Borel J (1991) Mechanism of action of cyclosporin-A and rationale for its use in nephrotic syndrome. Clin Nephrol 35 23-30.
4. Carlson SL, Parrish ME, Springer JE, Doty K, Dossett L (1998) Acute inflammatory response in spinal cord following impact injury. Exp Neurol 151, 77-88.
5. Casella GT, Bunge MB, Wood PM (2006) Endothelial cell loss is not a major cause of neuronal and glial cell death following contusion injury of the spinal cord. Exp Neurol 202, 8-20.
6. Chen ZJ, Negra M, Levine A, Ughrin, Levine JM (2002) Oligodendrocyte precursor cells: Reactive cells that inhibit axon growth and regeneration. J Neurocytol 31, 481-495.
7. Clausen T, Bullock R (2001) Medical treatment and neuroprotection in traumatic brain injury. Curr Pharm Des 7, 1517-1532.
8. Diaz-Ruiz A, Rios C, Duarte I (2000) Lipid peroxidation inhibition in spinal cord injury: Cyclosporin-A vs. methylprednisolone. Neuroreport 11, 1765-1767.
9. Diaz-Ruiz A, Rios C, Duarte I, Correa D, Guízar-Sahagún G, Grijalva I (1999) Cyclosporin-A inhibits lipid peroxidation after spinal cord injury in rats. Neurosci Lett 266, 61-64.
10. Diaz-Ruiz A, Vergara P, Perez-Severiano F, et al. (2005) Cyclosporin-A inhibits constitutive nitric oxide synthase activity and neuronal and endothelial nitric oxide synthase expression after spinal cord injury in rats. Neurochem Res 30, 245-251.
11. Dietz V, Curt A (2006) Neurological aspects of spinal cord repair: promises and challenges. The Lancet Neurol 5, 688-694.
12. Faulkner JR, Herrmann JE, Woo MJ, Tansey KE, Doan NB, Sofroniew MV (2004) Reactive astrocytes protect tissue and preserve function after spinal cord injury. J Neurosci 24, 2143-2155.
13. Fawcett JW, Asher RA (1999) The glial scar and central nervous system repair. Brain Res Bull 49, 377-391.
14. Fidler PS, Schuette K, Asher RA, et al. (1999) Comparing astrocytic cell lines that are inhibitory or permissive for axon growth: The major axon-inhibitory proteoglycan is NG2. J Neurosci 19, 8778-8788.
15. Guzmán-Lenis MS, Vallejo C, Navarro X, Casas C (2008) Analysis of FK506-mediated protection in an organotypic model of spinal cord damage: Heat shock protein 70 levels are modulated in microglial cells. Neuroscience 155, 104-113.
16. Horky LL, Galimi F, Gage FH, Horner PJ (2006) Fate of endogenous stem/ progenitor cells following spinal cord injury. J Comp Neurol 498, 525-538.
17. Howard CV, Reed MG (2005) Unbiased Stereology. 2nd edn, p. 256, New York: Bio Scientific Publishers, Oxford.
18. Hulesbosch CE (2002) Recent advances in pathophysiology and treatment of spinal cord injury. Adv Physiol Educ 26, 238-255.
19. Ibarra A, Correa D, Willms K, et al. (2003) Effects of Cyclosporin-A on immune response, tissue protection and motor function of rats subjected to spinal cord injury. Brain Res 979, 165-178.
20. Ibarra A, Diaz-Ruiz A (2006) Protective effect of Cyclosporin-A in spinal cord injury: An overview. Curr Med Chem 13, 2703-2710.
21. Ibarra A, Hernández E, Lomeli J, et al. (2007) Cyclosporin-A enhances non-functional axonal growing after complete spinal cord transection. Brain Res 1149, 200-209.
22. Ikegami T, Nakamura M, Yamane J, et al. (2005) Chondroitinase ABC combined with neural stem/progenitor cell transplantation enhances graft cell migration and outgrowth of growth-associated protein-43-positive fibers after rat spinal cord injury. Eur J Neurosci 22, 3036-3046.
23. Kaminska B, Gaweda-Walerych K, Zawadzka M (2004) Molecular mechanisms of neuroprotective action of immunosuppressants-facts and hypotheses. J Cell Mol Med 8, 45-58.
24. Ke Y, Chi L, Xu R, Luo C, Gozal D, Liu R (2006) Early response of endogenous adult neural progenitor cells to acute spinal cord injury in mice. Stem Cells 24, 1011-1019.
25. Klapka N, Hermanns S, Straten G, et al. (2005) Suppression of fibrous scarring in spinal cord injury of rat promotes long-distance regeneration of corticospinal tract axons, rescue of primary motoneurons in somatosensory cortex and significant functional recovery. Eur J Neurosci 22, 3047-3058.
26. Klapka N, Müller HW (2006) Collagen matrix in spinal cord injury. J Neurotrauma 23, 422-435.
27. Kwon BK, Tetzlaff W, Grauer JN, Beiner J, Vacarro AR (2004) Pathophysiology and pharmacologic treatment of acute spinal cord injury. Spine J 4, 451-464.
28. Lautermilch NJ, Spitzer NC (2000) Regulation of calcineurin by growth cone calcium waves controls neurite extension. J Neurosci 20, 315-25.
29. López-Vales R, García-Alías G, Forés J, et al. (2005) FK 506 reduces tissue damage and prevents functional deficit after spinal cord injury in the rat. J Neurosci Res 81, 827-836.
30. Massey JM, Amps J, Viapiano MS, et al. (2008) Increased chondroitin sulfate proteoglycan expression in denervated brainstem targets following spinal cord injury creates a barrier to axonal regeneration overcome by chondroitinase ABC and neurotrophin-3. Exp Neurol 209, 426-445.
31. Mayhew TM (1992) A review of recent advances in stereology for quantifying neural structures. J Neurocytol 21, 313-328.
32. McTigue DM, Wei P, Stokes BT (2001) Proliferation of NG2-positive cells and altered oligodendrocyte numbers in the contused rat spinal cord. J Neurosci 21, 3392-3400.
33. Miyata K, Omori N, Uchino H, et al. (2001) Involvement of the brain-derived neurotrophic factor/TrkB pathway in neuroprotecive effect of cyclosporin A in forebrain ischemia. Neuroscience 105, 571-578.
34. Mori K, Ikeda J, Hayashi O (1990) Monoclonal antibody R2D5 reveals midsagittal radial glial system in postnatally developing and adult brainstem. Proc Natl Acad Sci USA 87, 5489-5493.
35. Nottingham S, Knapp P, Springer J (2002) FK506 treatment inhibits Caspase-3 activation and promotes oligodendroglial survival following traumatic spinal cord injury. Exp Neurol 177, 242-251.
36. Okada S, Nakamura M, Katoh H (2006) Conditional ablation of Stat3.or Socs 3 discloses a dual role for reactive astrocytes after spinal cord injury. Nat Med 12, 829-834.
37. Okano H (2006) Adult neural stem cells and central nervous system repair. Ernst Schering Res Found Workshop 60, 215-228.
38. Olson EN, Williams RS (2000) Calcineurin signaling and muscle remodeling. Cell 101, 689-692.
39. Pencalet P, Serguera C, Corti O, Privat A, Mallet J, Gimenez y Ribotta M (2006) Integration of adult astrocytes into the lesioned rat spinal cord. J Neurosci Res 83, 61-67.
40. Pizzi MA, Crowe MJ (2006) Transplantation of fibroblasts that overexpress matrix metalloproteinase-3 into the site of spinal cord injury in rats. J Neurotrauma 23, 1750-1765.
41. Pyrzynska B, Lis A, Mosieniak G, Kaminska B (2001) Cyclosporin A-sensitive signaling pathway involving calcineurin regulates survival of reactive astrocytes. Neurochem Int 38, 409-415.
42. Rabchevsky AG, Fugaccia I, Sullivan PG, Scheff SW (2001) Cyclosporin a treatment following spinal cord injury to the rat: Behavioral effects and stereological assessment of tissue sparing. J Neurotrauma 18, 513-22.
43. Sayer FT, Kronvall E, Nilsson OG (2006) Methylprednisolone treatment in acute spinal cord injury: The myth challenged through a structured analysis of published literature., Spine J 6, 335-343.
44. Serrano AL, Murgia M, Pallafacchina G, et al. (2001) Calcineurin controls nerve activity-dependent specification of slow skeletal muscle fibers but not muscle growth. Proc Natl Acad Sci U S A 98, 13108-13113.
45. Sullivan PG, Rabchevsky AG, Waldmeier PC, Springer JE (2005) Mitochondrial permeability transition in CNS trauma: Cause or effect of neuronal cell death? J Neurosci Res 79, 231-239.
46. Vallières N, Berard JL, David S, Lacroix S (2006) Systemic injections of lipopolysaccharide accelerates myelin phagocytosis during Wallerian degeneration in the injured mouse spinal cord. Glia 53, 103-113.
47. Yamaguchi T, Miyata K, Shibasaki F, et al. (2006) Effect of cyclosporin A on immediate early gene in rat global ischemia and its neuroprotection. J Pharmacol Sci 100, 73-81.
48. Yu G, Hess DC, Borlongan CV (2004) Combined cyclosporine-A and methylprednisolone treatment exerts partial and transient neuroprotection against ischemic stroke. Brain Res 1018, 32-37.